Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

FLEXION THERAPEUTICS, INC.

(FLXN)
OverzichtKoersenGrafiekenNieuwsRatingsOndernemingFinanciŽnBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op FLEXION THERAPEUTICS, INC.
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index
2021FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera..
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021FLEXION THERAPEUTICS INVESTOR ALERT : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Results of Operatio..
2021Health Care Stocks Sliding in Late Monday Trading
2021SHAREHOLDER ALERT : Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained..
2021Top Midday Gainers
2021FLEXION MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S..
2021Health Care Stocks Trade Lower Premarket Monday
2021Wall Street Declines on Soaring Energy Prices
2021FLEXION THERAPEUTICS : Agrees to Be Acquired by Pacira BioSciences; Shares Soar Pre-Bell
2021Top Premarket Gainers
2021Pacira adds non-opioid pain drugs with $427.5 million Flexion buy
2021PACIRA BIOSCIENCES : to buy Flexion for $427.5 million
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under†Nasdaq Listing Rule 5635(c)(4)
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Biotechnology Select Industry..
2021Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Co..
2021FLEXION THERAPEUTICS : to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTA in American Academy of Orthopaedic ..
2021Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTAģ in American Academy of Orthopaedic..
2021Flexion Therapeutics Announces Inclusion of ZILRETTAģ in American Academy of Orthopaedi..
2021FLEXION THERAPEUTICS : Expands Early Stage Study of Drug Candidate for Post-Operative Pain..
2021FLEXION THERAPEUTICS : Announces Expansion of Phase 1b Trial Investigating FX301 for the M..
2021Flexion Therapeutics Announces Expansion of Phase 1B Trial Investigating Fx301 for the ..
2021FLEXION THERAPEUTICS : Announces Publication of Results from Phase 2 Pharmacokinetics (PK)..
2021Flexion Therapeutics, Inc. Announces Publication of Results from Phase 2 Pharmacokineti..
2021FLEXION THERAPEUTICS : Q2 2021 Commercial Metrics Overview - August 4, 2021
2021FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results and Recent Business H..
2021FLEXION THERAPEUTICS : Q2 Earnings Snapshot
2021FLEXION THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 3..
2021FLEXION THERAPEUTICS : Earnings Flash (FLXN) FLEXION THERAPEUTICS Reports Q2 Revenue $28.2..
2021FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results†and Recent Business H..
2021Flexion Therapeutics, Inc. Reiterates Net Sales Guidance for the Full Year 2021
2021FLEXION THERAPEUTICS : to Report Second-Quarter 2021 Financial Results on August 4, 2021
2021FLEXION THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
2021Flexion Therapeutics, Inc. Announces Resignation of Patrick Mahaffy as A Member and Cha..
2021Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
2021Flexion Therapeutics, Inc. Announces Appointment of Utpal Koppikar to Board of Director..
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021FLEXION THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
2021FLEXION THERAPEUTICS : Q1 Earnings Snapshot
2021Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Confe..
2021FLEXION THERAPEUTICS : Names New Chief Medical Officer
2021Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Ch..
2021Flexion Therapeutics, Inc. Appoints William T. Andrews as Chief Medical Officer, Effect..
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virt..
2021Seres Therapeutics Names David Arkowitz Chief Financial Officer
2021FLEXION THERAPEUTICS : Reports First-Quarter 2021 Financial Results and Recent Business Up..
2021Flexion Therapeutics to Present at the RBC Capital Markets 2021 Virtual Global Healthca..
2021FLEXION THERAPEUTICS : Q1 Loss Narrows as Revenue Rises
2021FLEXION THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
2021Flexion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 3..
2021FLEXION THERAPEUTICS INC : Results of Operations and Financial Condition, Change in Direct..
2021FLEXION THERAPEUTICS : Earnings Flash (FLXN) FLEXION THERAPEUTICS Posts Q1 Revenue $24.6M,..
2021Flexion Therapeutics, Inc. Appoints Frederick W. Driscoll as Principal Financial Office..
2021Flexion Therapeutics, Inc. Announces Changes in Chief Financial Officer, Effective May ..
2021Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business U..
2021Flexion Therapeutics, Inc. Provides Sales Guidance for 2021
1  2  3  4  5  6  7Volgende